Association between advanced lung cancer inflammation index and chronic kidney disease: a cross-sectional study.

Front Nutr

The Nephrology Department of Shanxi Provincial People's Hospital, Shanxi Medical University, Taiyuan, China.

Published: October 2024

AI Article Synopsis

  • - This study investigates the relationship between the advanced lung cancer inflammation index (ALI) and chronic kidney disease (CKD), focusing on how malnutrition and inflammation may impact CKD progression.
  • - Using data from the National Health and Nutrition Examination Survey (NHANES) involving 39,469 adults, researchers found a significant negative correlation between ALI levels and the risk of CKD, suggesting that higher ALI is associated with lower CKD risk.
  • - The results indicate an L-shaped relationship between ALI and CKD, with a saturation point at an ALI value of 55.09, and this negative association was consistent across various demographic and health factors, though further large-scale studies are needed for validation. *

Article Abstract

Background: Chronic kidney disease (CKD) is one of the common chronic diseases, and malnutrition and inflammation play a key role in the development of CKD. The advanced lung cancer inflammation index (ALI) is a novel index of nutrition and inflammation, and its association with CKD has not yet been clarified. The aim of this study was to explore the potential association between ALI and CKD.

Methods: We conducted a cross-sectional survey using data extracted from the National Health and Nutrition Examination Survey (NHANES, 2003-2018). Weighted multivariate logistic regression was used to assess the association between ALI and CKD, and smoothed curve fitting and threshold effect analyses were used to describe the nonlinear association between ALI and CKD. Subgroup analyses were performed to further assess the influence of other covariates on the relationship between ALI and CKD.

Results: A total of 39,469 adult participants were included in the study, of whom 7,204 (18.25%) were diagnosed with CKD. After adjusting for multiple confounders, we found a significant negative correlation between ALI and CKD (OR = 0.93; 95%CI, 0.91-0.95;  < 0.0001). The risk of CKD tended to decrease with increasing quartiles of ALI. Smoothed curve fitting showed an L-shaped negative correlation between ALI and CKD. Threshold analysis showed a saturation effect of ALI at the inflection point of 55.09. Subgroup analyses and interaction tests showed that this negative association was maintained across age, sex, race, BMI, diabetes, hypertension, cardiovascular disease, and cancer subgroups (P for interaction >0.05).

Conclusion: Our findings suggest a significant correlation between ALI and CKD in the US adult population. However, more large-scale prospective studies are still needed to further confirm our findings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486730PMC
http://dx.doi.org/10.3389/fnut.2024.1430471DOI Listing

Publication Analysis

Top Keywords

ali ckd
16
association ali
12
advanced lung
8
lung cancer
8
cancer inflammation
8
chronic kidney
8
kidney disease
8
ckd
8
correlation ali
8
ali
7

Similar Publications

Purpose: Chronic kidney disease (CKD) affects pulmonary and cardiovascular systems. This study evaluates functional and pulmonary capacity in pediatric patients with CKD stages 1 to 5.

Methods: Medical records of 30 pediatric CKD patients (stages 1-5) from December 2019 to February 2021 were analyzed.

View Article and Find Full Text PDF

Background: Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus (T2D) is critical, yet evidence of adherence to guideline-recommended standards in routine care remains unclear. We aimed to assess primary care adherence to guideline-recommended standards for patients with overlapping HF, CKD and T2D in England.

Methods: Using UK Clinical Practice Research Datalink (1998-2020), we evaluated care adherence across 161 529 individuals with HF, CKD or T2D before and after developing a second of these conditions.

View Article and Find Full Text PDF

Effect of Riociguat on Adenine-Induced Chronic Kidney Disease in Rats.

Biology (Basel)

February 2025

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box 35, Muscat 123, Oman.

Riociguat is a soluble guanylate cyclase (sGC) activator that increases the levels of cyclic guanosine monophosphate (cGMP). cGMP is known to play a key role in regulating kidney function. This research sought to investigate the possible protective effects of riociguat on the kidneys in the context of chronic kidney disease (CKD).

View Article and Find Full Text PDF

Introduction: Liver-kidney-metabolic health (LKMH) depends on complex interactions between metabolic dysfunction-associated steatotic liver disease (MASLD), chronic kidney disease (CKD), sex, and reproductive status. This study evaluates in a holistic manner how LKMH, sex, and menopause influence coronary artery calcification (CAC) burden.

Methods: Patients without previous cardiovascular disease were prospectively recruited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!